Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
6 When to speak to a healthcare professional Speak to your GP or a regulated UK clinician if you experience any of the following: Nausea or vomiting that lasts more than 24 hours, or that stops you from keeping fluids down Persistent or severe abdominal pain, especially if it radiates to your back (a possible sign of pancreatitis) Sudden, severe pain in the upper right side of your abdomen (a possible sign of gallstones or gallbladder inflammation) Persistent burning, tingling, or unusual skin sensitivity Palpitations, a sustained racing heart, dizziness, or chest discomfort Yellowing of the skin or eyes, dark urine, or pale stools (possible signs of liver problems) Signs of dehydration: dry mouth, low urine output, dizziness on standing, confusion Low mood, anxiety, or thoughts of self-harm If you bought retatrutide online and notice any new or unexpected symptoms Retatrutide isnt currently MHRA-approved
References How New GLP-1 Pill Compares to Shots for Weight Loss
I have been a Certified Diabetes Educator since 1986 and in all those years cant recall a case of thyroid cancer from taking a GLP-1
Weve got a really cool expedition to Venezuela, it sounds like
